Oxaprozin
Back to searchMolecule Structure
Scientific Name
Oxaprozin
Description of the Drug
Oxaprozin is an NSAID used to treat osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00991
http://www.drugbank.ca/drugs/DB00991
Brand Name(s)
Daypro, Oxaprozin
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Teva Pharmaceuticals Usa Inc, Watson Laboratories, Sandoz Inc, Sun Pharmaceutical Industries Inc, Actavis Elizabeth Llc, Dr Reddys Laboratories Ltd, Chartwell Life Molecules Llc, Mylan Pharmaceuticals Inc, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cyclooxygenase | PROTEIN FAMILY | INHIBITOR | CHEMBL2094253 |
Clinical Trial(s)
Unichem Links
| Atlas | oxaprozin | ||
| SureChEMBL | SCHEMBL3286 | ||
| PharmGKB | PA450730 | ||
| Human Metabolome Database | HMDB0015126 | ||
| DrugBank | DB00991 | ||
| PubChem: Thomson Pharma | 14922602 | ||
| PubChem | 4614 | ||
| Mcule | MCULE-7099031811 | ||
| LINCS | LSM-2553 | ||
| Nikkaji | J10.781F | ||
| PDBe | BJ6 | ||
| BindingDB | 50002861 | ||
| EPA CompTox Dashboard | DTXSID1045118 | ||
| DrugCentral | 2013 | ||
| ChemicalBook | CB1272505 | ||
| Guide to Pharmacology | 7252 | ||
| rxnorm | OXAPROZIN POTASSIUM | DAYPRO | OXAPROZIN |
| PubChem: Drugs of the Future | 12013314 | ||
| KEGG Ligand | C07356 | ||
| ChEBI | 7822 | ||
| ZINC | ZINC000049643479 |
